In the BioHarmony Drug Report Database
Mitoxantrone
Novantrone (mitoxantrone) is a small molecule pharmaceutical. Mitoxantrone was first approved as Novantrone on 1987-12-23. It is used to treat breast neoplasms, lymphoma, multiple sclerosis, myeloid leukemia acute, and pain amongst others in the USA. It is known to target DNA topoisomerase 2-alpha and DNA topoisomerase 2-beta.
Trade Name
|
Novantrone |
|---|---|
Common Name
|
mitoxantrone |
ChEMBL ID
|
CHEMBL58 |
Indication
|
breast neoplasms, lymphoma, multiple sclerosis, myeloid leukemia acute, pain, prostatic neoplasms, sarcoma |
Drug Class
|
Antineoplastics, anthraquinone derivatives |
Image (chem structure or protein)